We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
On Dec 23, we issued an updated research report on IDEX Corporation (IEX - Free Report) .
Over the past month, this Zacks Rank #3 (Hold) stock has returned 6.5% compared with the industry’s growth of 2.1%.
Scenario at Present
IDEX has been benefiting from its diversified business structure, solid product portfolio, execution abilities and growth investments. Also, the company has been steadily strengthening business through acquisitions. In this regard, in July 2019, IDEX acquired Velcora Holding AB with its Steridose and Roplan businesses. The buyout has been strengthening the sealing solutions platform. Notably, acquired assets had a positive impact of 1% on sales in the third quarter of 2019.
Also, the company’s healthy cash flow allows management to return higher values to its shareholders. Notably, in the first three quarters of 2019, it repurchased shares worth $54.7 million and paid out dividends totaling $109.2 million. The quarterly dividend rate currently stands at 50 cents per share (a hike of 16% was announced in May 2019). Share count exiting the third quarter was roughly 76.6 million. We believe that further share buybacks by the company will help in improving its bottom line.
However, in the last five years (2014-2018), the company’s cost of sales rose 2.6% (CAGR), while operating expenses grew 1.3% (CAGR). Notably, its cost of sales increased 0.5% year over year in the first three quarters of 2019. As noted by the company, rise in engineering costs played spoilsport in the quarter. We believe that any unwarranted rise in the cost of sales (due to ongoing trade disputes with foreign countries and inflation in commodity prices) and operating expenses might be detrimental to IDEX's performance, going forward.
Key Picks
Some better-ranked stocks from the same space are Kaman Corporation , Barnes Group, Inc. (B - Free Report) and DXP Enterprises, Inc. (DXPE - Free Report) . While Kaman currently sports a Zacks Rank #1 (Strong Buy), Barnes Group and DXP Enterprises carry a Zacks Rank of 2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Kaman delivered a positive earnings surprise of 7.72%, on average, in the trailing four quarters.
Barnes Group delivered a positive earnings surprise of 4.21%, on average, in the trailing four quarters.
DXP Enterprises pulled off a positive earnings surprise of 17.67%, on average, in the trailing four quarters.
Just Released: Zacks’ 7 Best Stocks for Today
Experts extracted 7 stocks from the list of 220 Zacks Rank #1 Strong Buys that has beaten the market more than 2X over with a stunning average gain of +24.6% per year.
These 7 were selected because of their superior potential for immediate breakout.
Image: Bigstock
IDEX's (IEX) Prospects Encouraging Despite Escalating Costs
On Dec 23, we issued an updated research report on IDEX Corporation (IEX - Free Report) .
Over the past month, this Zacks Rank #3 (Hold) stock has returned 6.5% compared with the industry’s growth of 2.1%.
Scenario at Present
IDEX has been benefiting from its diversified business structure, solid product portfolio, execution abilities and growth investments. Also, the company has been steadily strengthening business through acquisitions. In this regard, in July 2019, IDEX acquired Velcora Holding AB with its Steridose and Roplan businesses. The buyout has been strengthening the sealing solutions platform. Notably, acquired assets had a positive impact of 1% on sales in the third quarter of 2019.
Also, the company’s healthy cash flow allows management to return higher values to its shareholders. Notably, in the first three quarters of 2019, it repurchased shares worth $54.7 million and paid out dividends totaling $109.2 million. The quarterly dividend rate currently stands at 50 cents per share (a hike of 16% was announced in May 2019). Share count exiting the third quarter was roughly 76.6 million. We believe that further share buybacks by the company will help in improving its bottom line.
However, in the last five years (2014-2018), the company’s cost of sales rose 2.6% (CAGR), while operating expenses grew 1.3% (CAGR). Notably, its cost of sales increased 0.5% year over year in the first three quarters of 2019. As noted by the company, rise in engineering costs played spoilsport in the quarter. We believe that any unwarranted rise in the cost of sales (due to ongoing trade disputes with foreign countries and inflation in commodity prices) and operating expenses might be detrimental to IDEX's performance, going forward.
Key Picks
Some better-ranked stocks from the same space are Kaman Corporation , Barnes Group, Inc. (B - Free Report) and DXP Enterprises, Inc. (DXPE - Free Report) . While Kaman currently sports a Zacks Rank #1 (Strong Buy), Barnes Group and DXP Enterprises carry a Zacks Rank of 2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Kaman delivered a positive earnings surprise of 7.72%, on average, in the trailing four quarters.
Barnes Group delivered a positive earnings surprise of 4.21%, on average, in the trailing four quarters.
DXP Enterprises pulled off a positive earnings surprise of 17.67%, on average, in the trailing four quarters.
Just Released: Zacks’ 7 Best Stocks for Today
Experts extracted 7 stocks from the list of 220 Zacks Rank #1 Strong Buys that has beaten the market more than 2X over with a stunning average gain of +24.6% per year.
These 7 were selected because of their superior potential for immediate breakout.
See these time-sensitive tickers now >>